Eisai Q3 FY2016 Financial Results 2017

Eisai presented Q3 FY2016 financial results for the nine-month period ending December 2016, showing operating profit of 57.6 billion yen (14.1% margin) with improved profitability versus the prior year. The presentation covers consolidated financial performance, revenue trends across international markets, and strategic business updates for the pharmaceutical company.